ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
Saved in:
| Title: | ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. |
|---|---|
| Authors: | Schifanella L; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Barnett SW; Novartis Vaccines and Diagnostics, Inc, Cambridge, Massachusetts, United States of America., Bissa M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Galli V; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Doster MN; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Vaccari M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Shen X; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America., Pal R; Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America., Montefiori DC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., LaBranche CC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America., Trinh HV; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America., Washington-Parks R; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Liyanage NPM; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Gorini G, Brown DR; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Liang F; Karolinska Institute, Stockholm, Sweden., Loré K; Karolinska Institute, Stockholm, Sweden., Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Magnanelli W; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Metrinko M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Kramer J; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Breed M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Alter G; Ragon Institute of MGH, MIT, and Harvard Cambridge, Boston, Massachusetts, United States of America., Ruprecht RM; Texas Biomedical Research Institute, San Antonio, Texas, United States of America., Franchini G; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2019 Dec 03; Vol. 15 (12), pp. e1008121. Date of Electronic Publication: 2019 Dec 03 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1008121 |
